3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
15
Thoracic
9
Genitourinary
8
Dermatologic
8
Breast
8
Gastrointestinal
7
Gynecologic
4
Sarcoma
2
Other solid neoplasm
1
Lymphoid
1
Conditions
Sarcoma
10
Sarcoma, Alveolar Soft Part
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Osteosarcoma
2
Neoplasms
2
Melanoma
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Vulvar Neoplasms
1
Urogenital Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Pancreatic Neoplasms
1
Obesity
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Interventions
pembrolizumab
5
Gemcitabine
5
Cisplatin
5
Carboplatin
5
Fluorouracil
4
Filgrastim
4
Cetuximab
3
fludarabine
2
cemiplimab
2
belinostat
2
atezolizumab
2
Temozolomide
2
Riluzole
2
Peripheral Blood Stem Cell Transplantation
2
Oncolytic Virotherapy
2
Nivolumab
2
Ipilimumab
2
Cyclophosphamide
2
Bortezomib
2
AH 111585
2
zanidatamab
1
vocimagene amiretrorepvec
1
trifluridine tipiracil drug combination
1
trastuzumab deruxtecan
1
toripalimab
1
spartalizumab
1
seribantumab
1
selpercatinib
1
repotrectinib
1
poly ICLC
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
atezolizumab
×
Sarcoma
×
Clear all
NCT04273061
2025-09-22
CAPTIV-8
British Columbia Cancer Agency
Phase 2
Recruiting
200 enrolled
NCT02423863
2020-12-17
Poly-ICLC
Oncovir, Inc.
Phase 2
Completed
26 enrolled